Acetyl Hexapeptide-60 Shea Butter Amide is a high-performance biomimetic peptide designed to mimic the effects of sirtuins, the proteins responsible for cellular longevity and DNA repair. By conjugating a hexapeptide with a lipid chain derived from Butyrospermum Parkii Butter, this molecule achieves superior skin penetration and enhances dermal firmness.
- INCI Name:
- Acetyl Hexapeptide-60 Shea Butter Amide
- Chemical/Scientific Name:
- N-Acetyl-L-hexapeptide-60, amide with Shea Butter fatty acids
- Common Aliases:
- Sirtuin-mimetic peptide, Lipo-peptide
| Category: | Active Substances |
| Source Origin: | Synthetic / Plant-derived hybrid |
| Comedogenic Rating: | 0-1 |
| Primary Industries: | Cosmeceuticals, Anti-aging skincare |
| Solubility: | Amphiphilic (Oil-dispersible) |
At a Glance: Properties & Effects
| Anti-Aging/Renewal | |
| Barrier Repair | |
| Penetration Enhancement | |
| Irritation Risk |
- Primary Benefits:
- Stimulates sirtuin-1 (SIRT1) expression to prolong cellular life and resilience.
- Reduces the appearance of deep expression lines and vertical wrinkles.
- Improves skin elasticity and restores facial volume by reinforcing the dermal matrix.
- Enhances skin barrier function through its lipid-conjugated structure.
- Potential Risks:
- Minimal risk; generally well-tolerated by sensitive skin types.
- Limited long-term independent clinical data compared to legacy peptides like Acetyl Hexapeptide 8.
Biological Action & Cosmetic Profile
Conjugating a specific hexapeptide sequence with fatty acids from Butyrospermum Parkii Butter creates a molecule with a unique affinity for the skin’s lipid bilayer. Unlike traditional water-soluble peptides that struggle to bypass the stratum corneum, this lipid-modified version utilizes its hydrophobic tail to facilitate deeper delivery into the epidermis and dermis. Once integrated, the peptide interacts with cellular pathways responsible for metabolic regulation.Cellular longevity is primarily managed by sirtuins, which are deacetylase enzymes that regulate DNA transcription and protein stability. Acetyl Hexapeptide-60 Shea Butter Amide acts as a SIRT1 activator, essentially “tricking” the skin into a state of heightened repair and protection. This action helps maintain the health of fibroblasts, the cells responsible for producing collagen and elastin, thereby preventing the sagging typically associated with chronological aging.Structural improvements observed after consistent use include a notable increase in dermal density. By promoting the synthesis of essential extracellular matrix components, the peptide helps fill in “empty” spaces within the skin’s architecture. This mechanical support results in a lifting effect, particularly around the nasolabial folds and jawline, where skin gravity-induced laxity is most prominent.
Broader Applications & Origins
Formulators frequently select this peptide for high-end night creams and “V-lift” serums targeting facial contouring. The synthesis of this ingredient represents an evolution in peptide technology, moving away from simple amino acid chains toward complex, bio-available lipid-peptide hybrids. While it is technically synthetic, the use of shea butter derivatives aligns it with modern “green chemistry” trends that seek to blend laboratory efficacy with botanical components.
Routine Integration
- Synergies:
- Retinoids: Combining this peptide with Retinol provides a dual approach to collagen synthesis and cellular turnover.
- Humectants: Using it alongside Glycerin or Sodium Hyaluronate ensures the skin remains plump while the peptide works on structural repair.
- Antioxidants: Pairing with Niacinamide or Tocopherol protects the newly stimulated SIRT1 pathways from oxidative damage.
- Conflicts:
- No known biochemical conflicts exist with other common skincare actives.
Clinical Consensus & Safety
Dermatological assessments categorize this peptide as non-irritating and non-sensitizing. While the Cosmetic Ingredient Review (CIR) Expert Panel has not released a standalone monograph for this specific hexapeptide-shea amide hybrid, both its parent components—hexapeptides and Butyrospermum Parkii Butter—have extensive safety records. Manufacturer-led clinical trials demonstrate significant reductions in wrinkle depth within 28 to 56 days of twice-daily application.
How does this peptide differ from Argireline?
While Acetyl Hexapeptide 8 (Argireline) focuses on inhibiting muscle contractions to prevent wrinkles, Acetyl Hexapeptide-60 Shea Butter Amide focuses on cellular longevity and structural repair via sirtuin activation. They are often used together for a comprehensive anti-aging strategy.
Is it suitable for oily or acne-prone skin?
Yes. Although it contains a shea butter derivative, the molecular structure is altered into an amide, which does not possess the same heavy, occlusive properties as pure Butyrospermum Parkii Butter. It is unlikely to clog pores when used in balanced formulations.
How long does it take to see results?
Clinical observations typically show initial improvements in skin smoothness within 4 weeks, with more significant lifting and firming effects appearing after 8 to 12 weeks of consistent use.